⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NCI News
Neo-Concept International Group Holdings Limited Class A Ordinary Shares
Cancer Biomarkers Market Research Report 2026: Asia Pacific is a High-potential Region Fueled by Increased Healthcare Spending, While Genetic and Epigenetic Segments Drive Innovation
globenewswire.com
NCI
Cancer Biomarkers Market Research Report 2026: Asia Pacific is a High-potential Region Fueled by Increased Healthcare Spending, While Genetic and Epigenetic Segments Drive Innovation
globenewswire.com
NCI
Rosen Law Firm Encourages Neo-Concept International Group Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – NCI
businesswire.com
NCI
Rosen Law Firm Encourages Neo-Concept International Group Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – NCI
businesswire.com
NCI
First Patients Enrolled in First-of-Its-Kind International Trial Harnessing the Immune System Against Childhood Cancers
businesswire.com
NCI
Five Global Teams Awarded $125 Million to Take on the Toughest Challenges at the Frontiers of Cancer Science
businesswire.com
NCI
Five Global Teams Awarded $125 Million to Take on the Toughest Challenges at the Frontiers of Cancer Science
businesswire.com
NCI
D. Boral Capital Acted as Lead Placement Agent to Neo-Concept International Group Holdings Limited (Nasdaq:NCI) in Connection with its ~$8,000,000 Follow-On Offering
accessnewswire.com
NCI
Neo-Concept International Group Holdings Limited Announces Closing of Approximately US$8.1 Million Public Offering of Class A Ordinary Shares
globenewswire.com
NCI
Neo-Concept International Group Holdings Limited Announces Pricing of Approximately US$8.1 Million Public Offering of Class A Ordinary Shares
globenewswire.com
NCI